Mod 1 antivirals Flashcards
antivirals
acyclovir indications
herpes zoster (shingles)
genital herpes
varicella
cold sores and genital sores
acyclovir mechanism of action
DNA polymerase inhibitor
terminates DNA chain during replication
acyclovir administration consideration
nephrotoxicity
antiviral patient education
significant fatigue
periods of rest encouraged
antiInfluenza generic med
oseltamivir
oseltamivir MOA
prevents release of virus from infected cells
oseltamivir administration considerations
decreases sx and shortens duration but doesn’t cure flu
start treatment w/in 48h of sx onset
antiretrovirals indications
illnesses like HIV
antiretrovirals MOA
impede replication
antiretrovirals administration considerations
impact renal fxn
monitor urine output and renal labs
acyclovir patient education
avoid sexual contact while lesions are present
fluid intake
acylclovir route
PO
IV
topical
NEVER IM OR SUBQ
acyclovir therepeutic effects
not a cure, improves sx
long term for prevention
acyclovir side effects
GI distress (taken on empty stomach)
burning upon application
acyclovir adverse effects
renal impairment
neuro problems
dehydration
oseltamivir side effects
GI distress (empty stomach)
skin/hypersensitivty reactions (DISCONTINUE)
anti-hepatitis drug
adefovir
adefovir administration considerations
PO
prolonged therapy based on patient status
can promote resistence to antiretrovirals if untreated HIV infx
adefovir therepeutic effects
maintains or improves liver fx while active disease is present
adefovir SE and AE
exacerbation of Hep B
nephrotoxicity
lactic acidosis
severe hepatomegally
Lamivudine-zidovudine indications
HIV- and1 HBV
decreases chance of acquiring AIDS and HIV related illnesses
Lamivudine-zidovudine administration considerations
higher dose for HIV
caution with renal impairment
HIV complications may still occur
transmission is still possible
Lamivudine-zidovudine SE/AE
lactic acidosis
severe hepatomegally
pancreatitis (DISCONTINUE)
triple-drug therapy for HIV
protease inhibitors (PIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Non-nucleoside reverse transcriptase inhibitors
(NNRTIs)